EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Aquablation as salvage therapy for benign prostatic hyperplasia: an international multicentre study

Anouk Leathead iD, Nick Lee iD, Adel Arezki iD, David Bouhadana iD, Liam Murad iD, Tarek Benzouak iD, Iman Sadri iD, Rosie Foucault, Aalya Hamouda iD, Jeffrey Sioufi iD, Ilan Ohana iD, Joshua Cabral iD und 13 weitere

BJU International · 2026-12 · 138 (6) · 1171-1179

DOI: 10.1111/bju.70481 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJU International, online erschienen am 07.10.2026. Verfasst von Anouk Leathead und 24 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Montreal, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Salvage Therapy, Aquablation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our objective was to evaluate the safety and effectiveness of Aquablation® as a salvage therapy in patients who underwent prior intervention for benign prostatic hyperplasia (BPH). Materials and Methods We retrospectively analysed 1887 consecutive men from the International Collaborative Aquablation Research Urology Society database between 2018 and 2024 who underwent Aquablation at one of four international centres. The cohort was divided into two groups based on the presence or absence of previous BPH intervention. Baseline characteristics, clinical and functional outcomes, and complication rates were compared between the two groups using analysis of variance and Kruskal–Wallis tests. Finally, exploratory sub‐analyses were performed in the salvage therapy group based on the type of prior BPH intervention.

Results

Among the study population of 1887 men, 109 (5.8%) patients had undergone prior BPH intervention, and the remaining 1778 (94.2%) patients served as a control cohort. Prostate volumes were similar between both groups (82.3 vs 78.0 mL; P = 0.18). There were no significant differences in perioperative complications, 30‐day readmission rates, surgical retreatment rates, or sexual function outcome scores (all P > 0.05). There were also similar improvements in maximum urinary flow rates, post‐void residuals, International Prostate Symptom Scores, and quality of life scores (all P > 0.05). When comparing outcomes based on the type of prior BPH intervention, there were no differences in terms of operative time, prostate volumes, presence of median lobe, or complication rates.

Conclusion

We observed no statistically significant differences in safety or effectiveness for Aquablation as a salvage therapy for recurrent lower urinary tract symptoms after BPH intervention. Aquablation should be offered to men for whom prior procedures have failed and who want to preserve continence and sexual function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaSalvage TherapyAquablationMaleHumansRetrospective StudiesAgedTreatment OutcomeMiddle Aged

Stichwörter der Autor:innen

Aquablationbenign prostatic hyperplasialower urinary tract symptomsretreatmentsalvage therapy

Autor:innen und Institutionen

  • Faculty of Medicine, University of Montreal, Montreal, QC, Canada.
  • Division of Urology, University of Montreal, Montreal, QC, Canada.
  • Division of Urology, McGill University, Montreal, QC, Canada.
  • Faculty of Medicine, McGill University, Montreal, QC, Canada.
  • Faculty of Medicine, University of Sherbrooke, Sherbrooke, QC, Canada.
  • Division of Urology, University of Vermont Medical Center, Burlington, VT, USA.

ORCID-Profile: Anouk Leathead, Nick Lee, Adel Arezki, David Bouhadana, Liam Murad, Tarek Benzouak, Iman Sadri, Aalya Hamouda, Jeffrey Sioufi, Ilan Ohana, Joshua Cabral, Gregory Raster, Abdulla Alameeri, Alexander Glaser, Tiago Rodrigues

Zitieren

APA

Leathead, A., Lee, N., Arezki, A., Bouhadana, D., Murad, L., Benzouak, T., Sadri, I., Foucault, R., Hamouda, A., Sioufi, J., Ohana, I., Cabral, J., Gannon, M., Raster, G., Nusbaum, D., Alameeri, A., Klein, J., Singh, I., Kearns, J., …, & Zorn, K. C. (2026). Aquablation as salvage therapy for benign prostatic hyperplasia: an international multicentre study. BJU International, 138(6), 1171-1179. https://doi.org/10.1111/bju.70481

Vancouver

Leathead A, Lee N, Arezki A, Bouhadana D, Murad L, Benzouak T, et al. Aquablation as salvage therapy for benign prostatic hyperplasia: an international multicentre study. BJU International. 2026;138(6):1171-1179. doi:10.1111/bju.70481

BibTeX
@article{Leathead2026,
  author = {Leathead, Anouk and Lee, Nick and Arezki, Adel and Bouhadana, David and Murad, Liam and Benzouak, Tarek and Sadri, Iman and Foucault, Rosie and Hamouda, Aalya and Sioufi, Jeffrey and Ohana, Ilan and Cabral, Joshua and Gannon, Margaret and Raster, Gregory and Nusbaum, David and Alameeri, Abdulla and Klein, John and Singh, Inderjit and Kearns, James and Marhamati, Shawn and Glaser, Alexander and Helfand, Brian and Elterman, Dean and Rodrigues, Tiago and Zorn, Kevin C},
  title = {Aquablation as salvage therapy for benign prostatic hyperplasia: an international multicentre study},
  journal = {BJU International},
  year = {2026},
  volume = {138},
  number = {6},
  pages = {1171--1179},
  doi = {10.1111/bju.70481}
}
Kostenlos starten →